Patent No. EP2508523 (titled "Polymorphs Of Dasatinib And Process For Preparation Thereof") was filed by Teva Pharmaceutical Industries Ltd on Oct 23, 2008. The application was issued on Apr 17, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| SYNTHON | Nov 3, 2016 | HAMM&WITTKOPP PATENTANWÄLTE PARTMBB |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Mar 21, 2019
Mar 21, 2019
Mar 15, 2019
Mar 6, 2019
Mar 6, 2019
Mar 6, 2019
Mar 6, 2019
Mar 6, 2019
Dec 7, 2018
Dec 7, 2018
Dec 3, 2018
Dec 3, 2018
Nov 30, 2018
Nov 30, 2018
Nov 15, 2018
Nov 15, 2018
Nov 15, 2018
Nov 15, 2018
Sep 20, 2018
Sep 17, 2018
Sep 17, 2018
Sep 14, 2018
Sep 13, 2018
Sep 13, 2018
Sep 7, 2018
Sep 7, 2018
Sep 7, 2018
Aug 31, 2018
Aug 30, 2018
Aug 30, 2018
Aug 30, 2018
Jul 23, 2018
Jul 23, 2018
Jul 23, 2018
Jul 23, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 18, 2018
Jul 6, 2018
Jul 6, 2018
Jul 2, 2018
Jul 2, 2018
Jul 2, 2018
Jul 2, 2018
May 4, 2018
Apr 30, 2018
Apr 30, 2018
Apr 30, 2018
Apr 30, 2018
Apr 30, 2018
Apr 30, 2018
Apr 11, 2018
Apr 10, 2018
Apr 9, 2018
Apr 6, 2018
Apr 6, 2018
Apr 6, 2018
Apr 6, 2018
Apr 5, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Apr 4, 2018
Oct 30, 2017
Oct 30, 2017
Oct 26, 2017
Oct 24, 2017
Oct 19, 2017
Oct 19, 2017
Oct 19, 2017
Oct 19, 2017
Oct 19, 2017
Oct 12, 2017
Jul 17, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jul 7, 2017
Jun 13, 2017
Jun 9, 2017
May 19, 2017
May 19, 2017
May 19, 2017
May 10, 2017
May 10, 2017
Apr 28, 2017
Apr 28, 2017
Apr 28, 2017
Jan 2, 2017
Jan 2, 2017
Nov 8, 2016
Nov 3, 2016
Nov 3, 2016
Nov 3, 2016
Nov 3, 2016
Nov 3, 2016
Nov 3, 2016
Nov 3, 2016
Feb 17, 2016
Jan 21, 2016
Dec 8, 2015
Dec 8, 2015
Dec 8, 2015
Nov 13, 2015
Nov 13, 2015
Nov 13, 2015
Nov 13, 2015
Nov 13, 2015
Nov 3, 2015
Oct 29, 2015
Oct 28, 2015
Oct 28, 2015
Oct 28, 2015
Oct 28, 2015
Oct 28, 2015
Oct 27, 2015
Oct 21, 2015
Oct 21, 2015
Oct 21, 2015
Oct 21, 2015
Jul 17, 2015
Jul 17, 2015
Jul 17, 2015
Jul 17, 2015
Jul 17, 2015
Feb 10, 2015
Feb 10, 2015
Feb 10, 2015
Feb 10, 2015
Nov 17, 2014
Nov 17, 2014
Jul 22, 2014
Jul 22, 2014
Jul 22, 2014
Jul 22, 2014
Jul 22, 2014
Mar 28, 2014
Mar 28, 2014
Mar 14, 2014
Mar 13, 2014
Mar 12, 2014
Aug 27, 2013
Aug 27, 2013
Aug 27, 2013
Aug 27, 2013
Aug 27, 2013
Aug 27, 2013
Mar 4, 2013
Feb 18, 2013
Jan 30, 2013
Jan 30, 2013
Jan 30, 2013
Dec 4, 2012
Nov 23, 2012
Nov 23, 2012
Nov 23, 2012
Nov 5, 2012
Oct 25, 2012
Sep 12, 2012
Sep 4, 2012
Sep 4, 2012
Aug 29, 2012
Jul 20, 2012
May 21, 2012
May 21, 2012
May 21, 2012
May 21, 2012
May 11, 2012
May 11, 2012
May 11, 2012
Apr 24, 2012
Apr 12, 2012
Mar 12, 2012
Feb 29, 2012
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
Dec 21, 2011
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009
May 19, 2009